Color Code
Brown

Enhancing Hand Hygiene in U.S. Healthcare and Community Settings

992
hand hygiene
Enhancing Hand Hygiene in U.S. Healthcare and Community Settings
United States of America
To expand on CDC’s efforts to improve hand hygiene in U.S. healthcare settings and communities by creating new materials tailored to key settings in specialty areas. In addition, this project will develop an educational component focused on the promotion of hand hygiene in community settings for the public, childcare providers, caregivers of young children, school teachers and students.

HIV Trial Network

986
Infectious Disease
HIV Trial Network
Thailand
To facilitate the formation of a HIV Trials Network to advance research, therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.

Serotyping of Pneumococcal Disease

976
infectious disease
Serotyping of Pneumococcal Disease
India
To develop a test with TaqMan array cards to evaluate all pneumococcal serotypes causing meningitis.
Emory University (Bill & Melinda Gates Foundation)
CDC’s National Center for Immunization and Respiratory Diseases; Emory University Rollins School of Public Health; National Institute for Communicable Diseases; Bill & Melinda Gates Foundation

Dissolving Microneedle Patch for MR Vaccination

969
infectious disease
Dissolving Microneedle Patch for MR Vaccination
United States of America
To support the development of a dissolving microneedle patch for measles and rubella (MR) vaccination.
UNICEF
CDC’s National Center for Immunization and Respiratory Diseases; CDC’s Center for Global Health; Georgia Institute of Technology; Micron Biomedical

Pneumococcal Conjugate Vaccine Impact Review

961
infectious disease
Pneumococcal Conjugate Vaccine Impact Review
United States of America
To provide a comprehensive literature search on Pneumococcal Conjugate Vaccine impact on immunogenicity, nasopharyngeal colonization, otitis media, pneumonia, invasive pneumococcal disease and mortality.
Johns Hopkins University (Bill & Melinda Gates Foundation)
CDC’s National Center for Immunization and Respiratory Diseases; Johns Hopkins Bloomberg School of Public Health; International Vaccine Access Center; World Health Organization

GAVI Alliance Partner Engagement Framework

971
infectious disease
GAVI Alliance Partner Engagement Framework
Afghanistan
Bangladesh
Burkina Faso
Democratic Republic of the Congo
Cameroon
Ethiopia
Gambia
Haiti
Indonesia
India
Cambodia
Mali
Myanmar
Mozambique
Nigeria
Nepal
Pakistan
Rwanda
Senegal
Uganda
Viet Nam
Zambia
Zimbabwe
To strengthen vaccine-preventable disease surveillance platforms to maximize their capacity to measure burden of disease and to monitor the impact of vaccines. Activities include improving immunization data quality; evaluating impact and implementation of vaccines (including oral cholera, rubella, and HPV); improving the quality and planning of measles and rubella campaigns; and strengthening surveillance for vaccine preventable diseases (meningitis, diphtheria and pertussis, intussusception).
GAVI
CDC's National Center for Immunization and Respiratory Diseases
Subscribe to Infectious Disease